Jacobs Levy Equity Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Jacobs Levy Equity Management's HALO Position: Q2 2026 in Review
Jacobs Levy Equity Management reduced its Halozyme (HALO) stake by 59% in Q2 2026, selling an estimated $31.8M and leaving 322,377 shares worth $25.2M. The position accounts for 0.09% of the portfolio, ranked #196.
Jacobs Levy Equity Management first reported a position in HALO in Q2 2015 and has held it in 22 quarters since. The position peaked at $65.9M in Q3 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Jacobs Levy Equity Management held 322,377 shares of Halozyme worth $25.2M as of Q2 2026.
- Jacobs Levy Equity Management sold 467,052 Halozyme shares in Q2 2026, an estimated $31.8M.
- Halozyme made up 0.09% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #196 holding.
- Jacobs Levy Equity Management first reported a position in Halozyme in Q2 2015 and has held it in 22 quarters since.
- Jacobs Levy Equity Management's Halozyme position peaked at $65.9M in Q3 2025.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.